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Abstract 
In children and adolescents from two areas of Costa 
Rica with contrasting gastric cancer risks, two factors 
suspected to be linked to the natural history of the 
disease were tested: serum antibodies to Helicobacter 
pylori and serum pepsinogen levels. One hundred fifty-
five subjects from the high-risk area of Turrubares 
were compared to 127 from the low-risk area of 
Hojancha. No significant differences were found in the 
prevalence of IgG or IgA antibodies to Helicobacter 
pylori between the two regions. The prevalence of IgG 
was 65.8% in the high-risk area and 72.4 in the low-
risk area, and that of IgA was 43% in both areas. The 
levels of pepsinogen, especially pepsinogen C, were 
significantly elevated in subjects with H. pylori 
antibodies in their serum. The mean levels of 
pepsinogen C in those negative, positive, and strong 
positive for H. pylori antibodies were 8.7, 14.3, and 
21.1 ng/ml. These findings suggest that H. pylori-
associated gastritis, predominantly of antral 
localization, is very prevalent in Costa Rican children 
and adolescents. Such gastritis might be associated with 
a high prevalence of intestinal metaplasia and a high 
gastric cancer risk in the inland, but not the coastal 
rural populations. H. pylori may therefore be an 
insufficient cause whose role in gastric carcinogenesis 
is contingent upon the presence of other factors. 
Introduction 
Stomach cancer is the most frequently occurring malig-
nant tumor in Costa Rica (1), and the mortality rate from 
this tumor is the highest for any type of cancer in the 
world at the present time (2). Large intracountry differ-
ences in the incidence rates of gastric cancer are reported 
in this small country of 2.5 million inhabitants and 51,000 
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km2. The regions with the highest rates of gastric cancer 
(84.2/100,000 in males) and of precancerous lesions are 
situated in the highland area of the center of the country, 
and those with the lowest rates (25.4/100,000) are in the 
lowland and coastal areas (1, 3). 
Helicobacter pylori infection has been linked to 
chronic gastritis, and recent studies have shown that it is 
also associated with an increased risk of gastric carcinoma 
(4, 5). Furthermore, it has been postulated that H. pylori 
infection during childhood might be one of the main 
determinants of stomach cancer risk later in life (6). 
Serum pepsinogen levels reflect the degree of gastric 
atrophy and therefore have been used as markers of 
precancerous lesions of the stomach (7, 8). Pepsinogen 
is present in the serum in two immunochemically distinct 
forms: PGI,2 produced by the oxyntic cells of the body 
of the stomach decrease with increasing degrees of 
chronic atrophic gastritis, and PGII, which originates from 
the gland cells throughout the stomach and from the 
Brunner's glands in the duodenum, shows less variation 
with gastric atrophy (9). 
In order to explore the reasons for contrasting gastric 
cancer risks in Costa Rica and to gather more information 
on the role of H. pylori infection in the early stages of 
gastric carcinogenesis, we have examined the prevalence 
of IgG and IgA serum antibodies for H. pylori and the 
serum levels of pepsinogens in a group of children and 
young adults from a rural area with a high incidence of 
gastric cancer (Turrubares) and from a rural area at low 
risk for gastric cancer (Hojancha). 
Materials and Methods 
Two areas were selected for the study: one county in 
Turrubares with an age-adjusted incidence rate of stom-
ach cancer of 49.2/100,000 and another in Hojancha 
with an incidence rate of 20.3/100,000 for the period of 
1984 to 1988. These two counties were selected be-
cause, despite having different incidence rates of stom-
ach cancer, they were similar in many respects: both 
were rural with a tropical climate (minimum temperature, 
26°C; maximum temperature, 33*C) and have mestizo 
populations of iow socioeconomic status, although the 
proportion of household heads who cultivated their own 
land was greater in the low-risk area (37.5%) than in the 
high-risk area (0%). A dietary survey conducted in the 
two study areas revealed similar dietary habits, although 
2 The abbreviations used are: PGI or PGA, pepsinogen I or pepsinogen 
A; PGII or PGC, pepsinogen II or pepsinogen C; Al, absorbance index. 
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Table 1 Prevalence of 1gG and IgA-H. pylori antibodies by age and study area in Costa Rica 
Study areas Age group (years) 
No. of 
subjects 
Anti-IgG 
% positive 
(Al > 0.32) Mean 
% positive 
(Al > 0.35) Mean 
High-risk 7-10 61 60.7 0.46 39.3 0.40 
11-13 48 66.7 0.51 47.9 0.37 
14-16 27 70.4 0.54 40.7 0.38 
17-20 19 73.7 0.53 47.4 0.46 
All ages 155 65.8 0.50 43.2 0.39 
P (test for 
linear trend) 
0.22 0.60 
Low-risk 7-10 36 57.1 0.41 30.6 0.29 
11-13 58 77.6 0.57 43.1 0.42 
14-16 22 80.9 0.65 54.5 0.46 
17-20 10 77.8 0.63 70.0 0.47 
Unknown 1 
All ages 127 72.4 0.54 43.3 0.40 
P (test for 
linear trend) 
0.05 0.01 
the intake of certain nutrients was lower in the high-risk 
area. Details of this survey will be published elsewhere. 
Two schools that were easily accessible by car and 
served the less isolated regions of the county were se-
lected in each study area. Ali children attending the 
selected schools were invited to participate, and over 
90% of them agreed to participate and were included in 
the study. 
Blood samples were collected from children and 
young adults from the two study areas: 153 from the 
high-risk area and 123 from the low-risk area. Children 
7-15 years of age were invited to participate at the 
schools, and those for whom consent was obtained from 
the parents (most of those invited) were included in the 
study. Subjects 15-20 years of age were invited to par-
ticipate through local leaders and locai health workers. 
A 5-10-m1 blood sample was collected from each partic-
ipant. On the day of collection serum samples were 
separated and stored at -20°C. After a few weeks, the 
frozen samples were transferred to the Netherlands and 
analyzed for H. pylori antibodies. The analyses for pep-
sinogens were done 2 years after collection and storage 
at -20°C in the same laboratory. 
Anti-H. pylori Antibodies. IgG and IgA specific antibodies 
against H. pylori were measured by a modified enzyme-
linked immunosorbent assay technique using conjugates 
labeled with immunoperoxidase specific for human IgA 
and 1gG as described by Pena et a/. (10). For standardi-
zation of the measurement of these antibodies, test con-
ditions were chosen such that the absorbance of the 
standard reference serum was 0.5 ± 0.1 for IgA and 1.0 
± 0.1 for IgG. These values were used to correct the 
absorbance given by the sera under study. The results 
were expressed as the Al: 
Al = 
Mean absorbance reading (n = 2) of patient's serum 
- mean absorbance of blank reading  
Mean absorbance reading (n = 2) of reference serum 
- mean absorbance of blank reading 
Correlation analysis of the immunoblotting and en-
zyme-linked immunosorbent assay results showed that 
at a serum dilution of 1:200 and under the conditions 
defined above, a serum with an At > 0.32 for IgG anti-
H. pylori was positive above the 95% level. A correlation 
analysis between IgG and IgA showed that an Al > 0.353 
for IgA-anti-H. pylori was positive above the 95% level. 
Under these conditions the sensitivities and specific-
ities of the serological assay were 89% and 88% for IgG 
and 78% and 88% for IgA when compared with H. pylori 
detected by culture or Warthin-Starry stain (10). 
Pepsinogen Levels. Pepsinogen A and C (PGI and PGII) 
were measured in duplicate by specific sensitive radio-
immunoassays (11). Purified human Pepsinogens A and 
C were used as standard preparations. Serum samples 
were diluted 10-fold for Pepsinogen A (PGA) and 5-fold 
for Pepsinogen C (PGC) and were incubated with labeled 
pepsinogen and antibody in a final volume of 1 ml, for 4 _ 
days, at 4°C. Free pepsinogen was subsequently sepa- : 
rated from antibody-bound pepsinogen by a double-
antibody solid-phase technique, and the pellets were 
counted in a gamma scintillation counter. All samples 
were measured in the same assays. Intraassay variation 
varied from 3 to 10% for PGA and from 13 to 15% for 
PGC. The detection limit for the PGA radioimmunoassay 
was 0.12 al/liter and for the PGC radioimmunoassay 1.8 
al/liter. Dilution curves of a serum sample containing 
high concentrations of the pepsinogens were parallel to 
the standard curve. Aliquots of a subsample of 20 sera 
were also tested at Dr. Samloff's laboratory using a radio-
immunoassay as described elsewhere (7). 
Differences in the mean values of H. pylori antibod-
ies and pepsinogen levels were compared using the t test 
after logarithmic transformation and the Mann-Whitney 
U test. Correlation between pepsinogen levels and H. 
pylon antibodies was tested using the Spearman's rank 
test. 
Results 
In the high-risk area a total of 65.8% of the subjects 
tested were positive for IgG H. pylori antibodies (AI > 
Table 2 Mean values of serum PGA and PGC levels (ng/mt) by age and study area 
Study areas Age (years) 
No. of 
subjects 
PGA PGC PGA/PGC 
Means (±SD) Means (±50) Means (±S0) 
High-risk 7-10 61 35.5 (±11.3) 13.5 (±7.2) 3.3 (±2.5) 
11-13 48 39.8 (±13.8) 16.1 (±13.1) 3.2 (±1.5) 
14-16 27 39.7 (±13.6) 13.4 (±6.6) 3.3 (±1.3) 
17-20 19 38.4 (±11.8) 12.7 (±7.7) 4.1 (±3.0) 
All ages 155 37.9 (±12.6) 14.2 (±9.3) 3.4 (±2.1) 
Low-risk 7-10 36 34.8 (±13.6) 11.0 (±7.2) 4.9 (±4.9) 
11-13 58 41.4 (±15.0) 15.2 (±8.6) 4.3 (±5.8) 
14-16 22 33.8 (±12.9) 14.4 (±11.2) 3.6 (±2.2) 
17-20 10 47.0 (±25.8) 18.1 (±12.7) 4.0 (±2.6) 
Unknown 1 
All ages 127 38.6 (±15.5) 14.1 (±9.2) 4.3 (±4.8) 
0.32), and 43.2% were positive for IgA antibodies (AI > 
0.35). The corresponding figures for the low-risk area 
were 72.4% and 43.3%. Table 1 shows the prevalence 
of IgG and igA antibodies to H. pylori by age in the two 
study areas. An increase in the prevalence of H. pylori 
antibodies with increasing age was observed, but the test 
for linear trend for the percentage of positives in the four 
age groups was significant only in the low-risk area (P = 
0.05 for IgG and 0.01 for IgA). The distribution of IgG 
antibodies in both high- and low-risk areas was clearly 
bimodal. No significant differences in the prevalence of 
IgG and IgA antibodies to H. pylori was found between 
males and females or between the high- and the low-risk 
areas for gastric cancer. 
Table 2 summarizes the results of the serum pepsi-
nogen levels. No differences were observed in the me-
dian or log-transformed mean levels of PGA, PGC, and 
in the PGA:PGC ratio between the two study areas. In 
both areas the distributions of PGA and PGC were 
skewed to the right, and no difference between the high-
and low-risk area was observed in any of the age groups 
with the exception of 7-10-year-old children, in whom 
PGC levels were significantly higher in the high-risk area 
than in the low-risk area (P = 0.022). 
The mean levels of both PGA and PGC were signif-
icantly higher for males than for females (t test for differ-
ence between means: P < 0.001 for PGA and P = 0.002 
for PGC). No correlation between PGA and PGC levels 
and age was observed among H. pylori-positive or H. 
pylori-negative children. 
The relationship between the levels of IgG H. pylori 
antibodies and pepsinogen levels is summarized in Table 
3. Higher levels of pepsinogens are observed in those 
positive or strongly positive for H. pylori antibodies, and 
this tendency was more marked for PGC. A positive 
correlation was found between the levels of both vari-
ables. The mean levels of PGC in those negative, positive, 
and strongly positive for H. pylori antibodies were 8.7, 
14.3, and 21.1 ng/ml, respectively. 
The values for PGA obtained in Dr. Samloff's labo-
ratory were on average twice as high as those obtained 
in the Netherlands, but those for PGC were only 10% 
higher. The correlation coefficient between the measure-
ments in the two laboratories was 0.76 for PGA (P < 
0.001), and for PGC it was 0.96 (P < 0.001). 
Based on the results of the 20 sera tested in the two 
laboratories a correction index was applied to the rest of 
the sera, and the following results were obtained: the 
proportion of children with low levels of PGA (below 20 
ng/ml) decreased from 3.6% to 0.7% and those with a 
low PGA:PGC ratio (<1.0) decreased from 2.5% to 0.4%. 
Concerning the relationship between the levels of 
H. pylori antibodies and pepsinogen levels, the propor-
tion (percentage) of those negative, positive, and strongly 
positive for H. pylori among those with high levels of 
PGA changed from 8.0, 18.3, and 26.5% to 64.8, 73.8, 
and 85%, and these proportions among those with high 
levels of PGC changed from 3.4, 18.3, and 42.7% to 5.7, 
32.5, and 57.4%. 
Our pepsinogen categories were chosen based on 
cutoff values used in previous studies to identify subjects 
likely to be affected by moderate or severe chronic 
atrophic gastritis (7). Since the use of these cutoff points 
in our study population might be questionable, we have 
plotted the serum values of PGA and PGC against the H. 
pylori IgG titers of those considered positive, as shown 
in Fig. 1. A positive correlation with H. pylori antibodies 
was observed for both PGA and PGC, but it was clearer 
for PGC (for PGA, r = 0.16, P = 0.025; for PGC, r = 0.36, 
P < 0.001). 
Table .3 IgG H. pylon antibodies and pepsinogen levels 
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1gG H. pylon 
antibodies (Al) 
No. of 
subjects 
Pepsinogen A Pepsinogen C 
<20 ng/ml 20-49 ng/ml a50 ng/ml <10 ng/ml 10-19 ng/ml ±20 ng/ml 
(55) (%) (%) (%) (%) 
Negative (±32) 88 5.7 86.4 8.0 63.6 33,0 3.4 
Positive (33-74) 126 3.2 78.6 18.3 22.2 59.5 18.3 
Strongly positive (a75) 68 1.5 72.1 26.5 8.8 48.5 42.7 
Total 282 3.6 79.4 17.0 31.9 48,6 19.5 
0 3. 	  
0.0 
• • 	 1 
0.4 	 0.8 1.2 	 1.8 	 2.0 
1.1 
1.0 
0.5• 
0.1-
0.7. 
0.8. 
0.5. 
0.4. 
• • 
• 
. • • 
Ig
G
 H.
Py
lo
ri 
an
tib
o d
y  M
or
o  
(A
l)  
• 
• 
• / 
• 
• 
• 
• // • • 	 .• 
• 
IgG
 H.
Py
lo
ri 
an
tib
o d
y  t
ite
rs
 
 
(A
l)  
0 	  
0.8 	 1.0 	 1.2 	 1.4 	 1.8 	 1.8 	 2.0 
Serum popoinogon A (log) 
452 Helkobarter pylori, Pepsinogens, and Gastric Cancer 
Serum popainegon C (log) 
Hg. 1. Correlation between serum pepsinogen levels and lgG H. pylori 
antibody levels. 
Discussion 
Our results show an extremely high prevalence (over 
60.0%) of IgG and IgA H. pylori antibodies in children 
and young adults in Costa Rica. We measured both IgG 
and IgA antibodies because although IgG correlates well  
with infection and is more sensitive than IgA, the latter 
has been found to be of particular value in the follow-up 
of patients (12). This finding is in sharp contrast with 
reports from developed countries at low risk for gastric 
cancer where H. pylori antibodies are found only excep-
tionally in people under 10 years of age and the preva-
lence in the age group between 10 and 20 years is usually 
less than 20% (13, 14). However, in Costa Rica the high 
prevalence of H. pylori antibodies was found both in 
high- and low-risk areas for precancerous lesions and for 
stomach cancer. Since H. pylori infection has shown 
intrafamilial clustering (15) we also compared the mean 
family size in both study areas and found no difference; 
it was 6.1 in the high-risk area and 6.3 in the low-risk 
area. Our results should be regarded with caution since 
they are based on a comparison of two areas only. In a 
recent ecological study conducted in serum samples 
from 46 counties in China, a significant but weak corre-
lation was found (r = 0.40; P = 0.02) between the 
prevalence of H. pylori antibodies and mortality rates for 
gastric cancer (16). 
Recent reports on the prevalence of H. pylori infec-
tion in different populations have pointed out remarkable 
differences between developing and developed coun-
tries. The former display a higher prevalence (over 60%) 
and an earlier age of onset of infection than the devel-
oped or affluent countries (13, 14, 17-21). This pattern 
has led to the hypothesis that an early age of H. pylori 
infection is an etiological factor in gastric carcinogenesis 
and that a lower rate of such infection in children may 
account for the decline in gastric cancer rates reported 
in most developed countries. However, this hypothesis 
does not account for some of the international differ-
ences in gastric cancer risk. Thus, some developing coun-
tries in which the H. pylori prevalence in children and 
adults is high display high rates of gastric cancer, i.e., 
Peru (22), Colombia, China, and Costa Rica (23), but 
others, such as Algeria, Ivory Coast, and Vietnam (22), 
appear to have low rates of cancer. 
In addition, the association between H. pylori infec-
tion, gastritis, and gastric cancer is not straightforward: 
diffuse antral gastritis related to duodenal ulcer is prob-
ably caused by H. pylori, but it is not associated with an 
increased risk of gastric cancer. In the case of multifocal 
atrophic gastritis, a precursor lesion of gastric cancer, 
other factors in addition to H. pylori are suspected to 
play an important etiological role, i.e., excessively salted 
foods and low intake of certain micronutrients such as fi- 
carotene and vitamin C (17). In this type of gastritis, H. 
pylori infection could be another source of chronic irri-
tation of the gastric mucosa, inducing excessive cellular 
proliferation (17, 18) and in this way enhancing carcino-
genesis. The role of H. pylori would then be similar to 
that of salt (NaCI), which is not a carcinogen in Itself but 
markedly enhances the carcinogenesis of genotoxic 
agents (24). In Costa Rica, the critical genotoxic damage 
to the gastric cells might be induced by N-nitrosocom-
pounds. This possibility is supported by a parallel study 
carried out in the children who are the subject of the 
present report. After praline ingestion, the excretion of 
nitrosoproline in the urine was higher in the children 
from the high-risk area than in children from the low-risk 
area, indicating a higher potential of in vivo formation of 
N-nitrosocompounds in the high-risk area (25). 
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Our results in Costa Rican children confirm the 
findings of high levels of PGA in H. pylori-positive chil-
dren with histologically confirmed gastritis as reported 
by Oderda et al. (26-27). Although we did not interview 
or examine the children for gastrointestinal symptoms, it 
is presumed that most of them were asymptomatic or 
had minor symptoms that did not prevent them from 
school attendance. At the moment the present manu-
script was submitted, no publication existed showing a 
strong correlation of PGC and H. pylori antibody levels. 
However, subsequently similar findings have been re-
ported before and after treatment of H. pylon infection 
(28) and in Dutch healthy blood transfusion donors (29). 
Errors in the measurement of pepsinogen levels are 
unlikely. PGC levels showed an excellent correlation 
between the U.S. and Dutch laboratories, but the cor-
relation of PGA was less satisfactory. 
It has been shown that H. pylori stimulates pepsi-
nogen secretion in vitro independently of toxic damage 
to cells and probably through mediation of a peptide 
smaller than Mr 12,000 (30). Thus, although endoscopy 
and gastric biopsies were not performed in the present 
study, the serum pepsinogen levels and their correlation 
with the H. pylori antibody titers suggest that a high 
proportion of these children actually had gastritis. Similar 
findings have been reported in children with nonspecific 
abdominal pain (26, 27). The much higher levels of PGC 
observed in the present study among those found to be 
positive or strongly positive for H. pylori antibodies than 
among the negative subjects suggest that there is in-
creased liberation of PGC as a result of antral gastritis. 
In general, gastric cancer risk is higher in populations 
with low levels of blood pepsinogens, especially PGA 
(31). On the other hand, our and other studies (27) 
suggest that H. pylori elevates blood levels of PG, espe-
cially PGC. This apparent incongruence may be ex-
plained by the fact that low PG levels reflect mostly 
atrophic and intestinalized mucosa, which is not colo-
nized by H. pylori. Anti-H. pylori antibodies are very 
prevalent in populations at high gastric cancer risk, even 
though morphological detection of H. pylori in them is 
low (32). In patients with extensive metaplasia, H. pylon 
infection in the nonatrophic mucosa is insufficient to 
raise PG blood levels. 
Our results indicate that Costa Rican children and 
adolescents have a high prevalence of H. pylori-associ-
ated antral gastritis. Such gastritis might be associated 
with a high prevalence of intestinal metaplasia and a high 
gastric cancer risk in the highlands but not in the coastal 
rural populations. H. pylori infection could therefore be 
regarded as an insufficient cause of intestinal metaplasia 
and of gastric cancer, whose effect is dependent on the 
simultaneous presence of other factors, such as certain 
vitamin deficiencies and exposure to genotoxic 
compounds. 
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